Monteris wins U.S. and Canadian nods for its NeuroBlate tumor "cooker"

Mon, 04/15/2013 - 2:29pm
Mass Device

Monteris Mecical scores regulatory wins in the U.S. and in Canada, also touting positive clinical trial results for the NeuroBlate MRI-guided brain tumor treatment system.

Monteris Medical logo

Monteris Medical won a regulatory nod in the U.S. and in Canada for its NeuroBlate MRI-guided tumor ablation device, the company said.

Monteris calls NeuroBlate a tumor "cooker" which uses an MRI-guided laser system to heat and kill brain tumors. Positive results in the 1st-in-human trials were published earlier this month in the Journal of Neurosurgery.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.